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ABSTRACT
It has previously been shown that transcription
greatly enhances recombination in mammalian
cells. However, the proteins involved in catalysing
this process and the recombination pathways
involved in transcription-associated recombination
(TAR) are still unknown. It is well established that
both the BRCA2 protein and the RAD51 paralog pro-
tein XRCC2 are required for homologous recombi-
nation. Here, we show that the BRCA2 protein is
also required for TAR, while the XRCC2 protein is
not involved. Expression of the XRCC2 gene in
XRCC2 mutated irs1 cells restores the defect in
homologous recombination repair of an I-SceI-
induced DNA double-strand break, while TAR is
unaffected. Interestingly, the XRCC2-deficient irs1
cells are also proficient in recombination induced
at slowed replication forks, suggesting that TAR is
mechanistically linked with this recombination path-
way. In conclusion, we show that TAR depends on
BRCA2 but is independent of XRCC2, and that this
recombination pathway is separate from that used
to repair a two-ended DNA double-strand break.
INTRODUCTION
Transcription-associated recombination (TAR) is con-
served in all cellular organisms investigated, from bacteria
to mammals (1). The mechanisms and underlying causes
of TAR are still largely unknown, as are the proteins cat-
alysing this process. Studies in Saccharomyces cerevisiae
has shown that a number of factor inﬂuence TAR; for
instance DNA damage appears to have a synergistic
eﬀect with transcription on the levels of recombination
(2). It has also been shown in S. cerevisiae that RNA
polymerase I-dependent transcription can result in colli-
sion with the replication machinery leading to replication
fork blockage and recombination in rDNA repeat copies
(3). RNA polymerase II transcription can also impair the
replication fork progression, which results in an increased
recombination (4). A similar increase in recombination
levels can be observed in S. cerevisiae strains with
impaired transcription elongation owing to mutations in
the THO/TREX complex (5,6). The THO/TREX complex
is active at the interface between transcription and mes-
senger ribonucleoprotein (mRNP) metabolism, and as a
consequence of the mRNP biogenesis defect in THO/
TREX mutants an impaired replication fork progression
could be observed, which appear to stimulate TAR (7).
Nickoloﬀ and Reynolds (8) were ﬁrst to show that tran-
scription stimulated homologous recombination in mam-
malian cells, using heteroallelic neomycin genes. TAR in
mammalian cells has been shown to also be associated
with replication and restricted to cells in the S phase of
the cell cycle (9). The available data thus suggest that TAR
is likely involved in bypassing an active RNA polymerase,
but details of the recombination mechanisms and proteins
involved in the process remain elusive.
Homologous recombination (HR) can be induced by
DNA double-strand breaks (DSBs) or at replication
forks (10–12). There are two major pathways by which
DSBs can be repaired; non-homologous end-joining
(NHEJ) or homologous recombination (HR). NHEJ is a
fast and error-prone repair pathway that involves ligation
of free ends (13), while homologous recombination is slow
and error-free if an intact DNA molecule, usually the
sister chromatid, is used in the repair (14,15). Several pro-
teins, e.g. BRCA2, RAD51 and ﬁve RAD51 paralogs,
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recombination repair of DSBs in mammalian cells
(16–19), and mutations in these genes often results in cel-
lular sensitivity to ionizing radiation. Chinese hamster
cells sensitive to ionizing radiation have been isolated
(20) and it was later found that one of the ﬁve RAD51
paralog genes, XRCC2, correct the ionizing radiation sen-
sitive hamster cell line irs1 (21). The precise function of
XRCC2 is unknown, but it has been shown to associate
with three other RAD51 paralogs; RAD51B, RAD51C
and RAD51D (22). This complex is called BCDX2 and
has been shown to bind single-stranded DNA as well as
single-stranded regions of DNA and to facilitate RAD51
ﬁlament formation (22). Cell lines deﬁcient in XRCC2 are
viable, but exhibit chromosomal aberrations, sensitivity to
cross-linking agents, a mild sensitivity to g-radiation (20)
and defective RAD51 foci formation (18).
Here, we investigated the connection between homolo-
gous recombination and TAR using well-characterized
Chinese hamster cell lines, irs1 and V-C8, deﬁcient in
XRCC2 and BRCA2, respectively (21,23). We ﬁnd that
BRCA2 defective cells are deﬁcient in TAR, showing
that TAR employs homologous recombination proteins.
Surprisingly, the XRCC2 defective irs1 cells are still able
to carry out TAR, in spite of being defective in homolo-
gous recombination of a DSB induced by ionizing radia-
tion or a restriction endonuclease. This genetically
separates TAR from DSB-induced homologous recombi-
nation. Furthermore, we show that XRCC2-deﬁcient irs1
cells are also proﬁcient in thymidine-induced recombina-
tion, which altogether suggest that TAR is employing a
similar recombination mechanism to bypass replication
blocks as for lesions produced by thymidine treatment.
MATERIALS AND METHODS
Cellculture
All cell lines used in this study are derived from V79
Chinese hamster cells, with an additional mutation in
BRCA2 (V-C8 and V-C8TofZM4), XRCC2
(irs1TofZM14 and irs1TofZM15) or with a partial dupli-
cation in the hprt gene S8TofZM5 (Table 1). The cells
were cultured in Dulbecco’s Modiﬁed Eagle Medium
with 10% fetal bovine serum and 1% PEST (penicillin–
streptomycin). To select for the desired clones and to keep
the inserted genes in the cells, 0.25mg/ml of zeocin and
120 U/ml hygromycin were added to the medium. In order
to keep the transcription of the recombination substrate
oﬀ during growth, 1mg/ml of doxycycline was also added
to the medium. The cells were cultured in an incubator at
378C with 5% CO2.
Transfection
The Chinese hamster cell lines were stably transfected with
a recombination substrate using electroporation. The plas-
mids were puriﬁed from Escherichia coli. Fifteen micro-
grams of plasmid DNA were used for each transfection.
The plasmid DNA was diluted in 50mld H 2O and mixed
with 7.5 10
6 cells in an electroporation cuvette. The cells
were transfected using the voltage 2.5kV/cm and the
capacitance 25mF. The electroporated cells were aliqo-
tated in the amounts 20, 50 and 100ml on Petri-dishes
and incubated for 2 days before the appropriate selective
agent was added. After the colonies had formed, 30 colo-
nies of varying sizes were picked and transferred to culture
plates for further cultivation. Transient transfection was
performed using Lipofectamine 2000 from Invitrogen
according to the manufacturer’s protocol.
Luciferase assay
For measuring luciferase activity individual clones were
trypsinised and counted and 2 10
5 cells from each
clone were incubated with and without doxycycline for
24h prior to lysis. After the incubation the cells were
rinsed twice with Dulbecco’s PBS w/o Ca and Mg. All
PBS was removed and 500ml of lysis buﬀer was added
to each well. The plates were shaken for 20min in order
to lyse the cells and the luciferase activity was measured
using an illuminator. Clones exhibiting low background
and high inducibility in the luciferase assay were selected
for further experiments.
Recombination assay
For measuring recombination 1 10
6 cells were seeded
onto four Petri-dishes. To two of the dishes, 10ml
(1mg/ml) of doxycycline was added to repress expression
from the Pbi-1 promoter. In the case of I-SceI-induced
recombination, the cells were transiently transfected
using Lipofectamine after 24h. After an additional 24h
the cells were plated on cloning and selection dishes to
determine survival and recombination, respectively. On
the cloning dishes, 500 cells were seeded and on the selec-
tion dishes 300000 cells were seeded. After 24h, 100mlo f
G418 was added. When colonies had formed (10 days for
cloning and 15 days for selection), the cells were stained,
using methylene blue in methanol (4g/l), and counted. The
recombination frequency was calculated as the number
of recombinants formed in relation to survival. Thus,
diﬀerential cloning eﬃciencies are compensated for in
the recombination assay. Recombination assays while
Table 1. Genotype and origin of Chinese hamster cell lines used in this
study
Cell line Genotype Defect/modiﬁcation Origin References
irs1TofZM14,15 XRCC2
  XRCC2
 , deﬁcient in homol-
ogous recombination, carry-
ing TAR substrate
V79 (37)
S8TofZM5 WT Wild-type Chinese hamster,
partical duplication in hprt
gene, carrying TAR substrate
V79 (38)
V-C8 BRCA2
  BRCA2
 , deﬁcient in
homologous recombination
V79 (23)
V-C8TofZM4 BRCA2
  BRCA2
 , deﬁcient in
homologous recombination,
carrying TAR substrate
V79 (23)
V79 WT Wild-type Chinese
hamster
Lung (23)
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For these assays, 20mg of XRCC2 plasmid (24) was
used for each 10-cm Petri-dish. One microgram of I-SceI
plasmid was used for each Petri-dish in order to induce a
DSB in the recombination substrate. Transient transfec-
tions were performed using Lipofectamine 2000 according
to the manufacturer’s protocol.
RAD51 foci
To score for Rad51 foci, cells were treated with ionizing
radiation or thymidine or left untreated as a control. For
cells that were transiently transfected with a plasmid con-
taining XRCC2, transfection was performed as described
previously. Irradiated cells were treated with 5Gy and left
in an incubator for 5h in order for foci to appear. For the
thymidine treatment, the cells were treated with 2mM of
thymidine for 24h. For Rad51 foci detection, 5 10
4 cells
per slide were seeded onto sterilized cover slides. The next
day the slides were either irradiated or treated with thy-
midine. After the treatment the cells were ﬁxed with 3%
paraformaldehyde containing 0.1% Triton X-100. The
cells were then rinsed with PBS containing 0.1% TX-100
2 10min. After rinsing the cells were permabilised with
PBS+0.3% TX-100 for 10min. The cells were then
blocked with PBS+3% BSA for 40min. After blocking,
the primary antibody, h92 Santa Cruz anti RAD51 poly-
clonal rabbit diluted 1:1000 in PBS+3% BSA was added
and the cells were left at 48C over night. The next day, the
cells were rinsed with PBS containing 0.1% TX-100. After
rinsing the cells were permabilized with PBS+0.3% TX-
100 for 10min. After permabilization, the secondary anti-
body was added; donkey anti rabbit alexa 555 from
Invitrogen, diluted 1:500 in PBS+3% BSA. The slides
were the incubated in the dark for 1h. The cells were then
rinsed with PBS containing 0.1% TX-100 2 10min and
permabilized with PBS+0.3% TX-100 for 10min. They
were then rinsed with PBS for 5min and stained with
ToPro from Invitrogen for 30min. The slides were then
rinsed with PBS for 5min and mounted with anti fade kit
and sealed with nail polish. The slides were coded to make
scoring impartial. Cells with more than 10 foci were scored
as positive and 200 cells per slide were scored.
Western blot
To conﬁrm that transient transfection with wild-type
XRCC2 increased the levels of the XRCC2 protein in
the cells, western blots were performed. An antibody
against XRCC2 diluted 1:200 was used. An antibody
against a-tubulin diluted 1:1000 was used as a loading
control. The proteins were extracted using lysis buﬀer
and the protein concentration was measured by using
the Coomassie (Bradford) Protein Assay Kit from
Pierce. A standard western blot protocol was used and
the proteins were separated on a NuPage Novex 10%
Bis–Tris gel from Invitrogen and then blotted onto a
PVDF membrane. The proteins were visualized using
SuperSignal Western blotting kit from Pierce.
RESULTS
BRCA2 isrequired forTAR
We have previously constructed a substrate to investigate
the eﬀect of transcription on homologous recombination
(9). Brieﬂy, the construct contains two non-functional
neomycin resistance genes; one neo repeat has a 18-bp
long recognition site for I-SceI inserted, which introduce
a stop codon that truncates the gene product, and the
second neo repeat has a 30 deletion and is called 50neo
(Figure 1A). A functional neo
R gene can be regained
either through gene conversion (GC) or sister chromatid
exchange (SCE), but not through single-strand annealing.
The truncated neo repeat is under the control of a
bi-directional inducible promoter based on a Tet-Oﬀ gene
expression system. Using this approach, the levels of tran-
scription over this neo repeat can be measured using the
expression levels of the luciferase gene, simultaneously
expressed in the opposite direction in the vector (9).
Here, we transfected wild-type, XRCC2 and BRCA2
mutated Chinese hamster cells with both the Tet-
regulatory vector pTetOﬀZeo and the recombination con-
struct pBI-LMScI and selected for individual clones resis-
tant to zeocin and hygromycin, to obtain cells with both
vectors stably integrated into the genome. Withdrawal
of doxycycline from the media resulted in increased luci-
ferase activity in both wild-type (S8TofZM5) and BRCA2
defective (V-C8TofZM4) cells (Figure 1B), showing that
BRCA2 does not inﬂuence the inducibility of transcription
on the recombination substrate.
Transcription on the recombination substrate enhanced
recombination levels in S8TofZM5 cells 3.7-fold
(Figure 1C), which is in agreement with what was reported
earlier for other wild-type hamster cells (9). However,
transcription did not induce recombination in BRCA2
defective V-C8TofZM4 cells (Figure 1C). This is expected
as the BRCA2 protein is vital for RAD51-mediated
recombination (17), and in particular the gene conversion
events produced by transcription (9,25). Here, we conﬁrm
the homologous recombination defect in BRCA2 defective
V-C8 cells and show that RAD51 foci cannot form
following either ionizing radiation [which has been
shown before (16)] or following thymidine treatments
(Figure 1D).
Transcription associated recombination is
independent ofXRCC2
We also studied TAR in XRCC2 mutated irs1 cells carry-
ing the Tet-regulatory vector pTetOﬀZeo and the recom-
bination construct pBI-LMScI. Transcription was
eﬃciently increased over the recombination substrate fol-
lowing removal of doxycycline from the media, as deter-
mined by measuring the luciferase activity (Figure 2A).
Surprisingly, both the irs1TofZM14 and irs1TofZM15
clones showed a 3.8- and 3.3-fold increase in TAR follow-
ing removal of doxycycline, respectively (Figure 2B), indi-
cating a functional recombination pathway. This was
unexpected as the XRCC2-defective irs1 clone earlier has
been shown to be defective in homology directed repair of
Nucleic AcidsResearch, 2009, Vol.37,No. 2 407DSBs (26,27) and to be defective in RAD51 foci formation
following ionizing radiation treatment (18,19).
To fully test if XRCC2 is not involved in TAR, we
transiently transfected irs1TofZM14 cells with the wild-
type XRCC2 in the pIRESneo2 vector and determined
expression using western blot (Figure 3A). We found
that expression of XRCC2 did not inﬂuence TAR levels
(Figure 3B), conﬁrming that the XRCC2 protein or
XRCC2 protein level have no function in TAR.
TAR ismechanistically distinct from homologous
recombination repairof DSBs
The irs1 cells used here have previously been reported to
be defective in DSB-induced homologous recombina-
tion repair of an I-SceI-induced DSB (27). We found
that transfection of the irs1 cell line with an XRCC2
expression vector did not inﬂuence TAR, which could
be explained by XRCC2 not being involved in TAR,
or alternatively, that the XRCC2 expressed in the
irs1TofZM14 is non-functional. As our recombination
construct contains an I-SceI site, we tested if the XRCC2
expressed in irs1TofZM14 cells could complement the
reported deﬁciency in homologous recombination. To
test this, we transiently transfected irs1TofZM14 cells
with both the pCMV3xnlsI-SceI vector and/or XRCC2
(24) with or without doxycycline. We found that the
XRCC2 vector eﬃciently reverts the defect in homology
directed DSB repair in irs1TofZM14 cells (Figure 4A);
showing that the over-expressed XRCC2 protein is func-
tional. Furthermore, we ﬁnd that the eﬀect of TAR is
additive, which is in agreement with earlier ﬁndings that
transcription does not inﬂuence the homology directed
repair of a DSB (9,28,29). Interestingly, we ﬁnd that
homologous recombination is induced by an I-SceI-
induced DSB also in non-complimented irs1TofZM14
cells (P<0.05), while the original report showed no induc-
tion of recombination in the same irs1 cells (27). The data
presented here suggests that irs1 cells are defective in
homologous recombination repair of I-SceI-induced
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Figure 1. BRCA2 is required for transcription-associated recombination. (A) Transcription-associated recombination is monitored between a
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pBI-LMscI vectors (9). (C) The recombination frequency was monitored as reversion to a functional neomycin resistant gene following removal of
doxycyclin, which increases transcription at the recombination substrate. Transcription enhanced recombination in wild-type S8TofZM5 (P<0.01 in
t-test), but not in BRCA2 defective V-C8TofZM4 (P>0.05 in t-test). (D) The number of cells with RAD51 foci was scored in BRCA2 defective V-C8
and parental V79 cell line 5h after irradiation with 5Gy or following 24h 2mM thymidine treatments. The numbers of cells with foci increased in
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average and standard deviation of three independent experiments is depictured in all experiments.
408 Nucleic Acids Research, 2009, Vol. 37,No. 2DSBs and are at the same time proﬁcient in TAR. Thus,
there might be a sub-pathway of homologous recombina-
tion repair in irs1 cells that is still functional. It was pre-
viously reported that irs1 cells are proﬁcient in thymidine-
induced RAD51 foci, but defective in hydroxyurea and g-
ray-induced RAD51 foci (30). Thymidine is an agent that
depletes only the (dCTP) pool in cells, as a consequence of
a negative feedback mechanism of the R1 subunit of ribo-
nucleotide reductase that follows high (dTTP) levels (31).
The consequence is that the progression of the replication
fork is slowed down during replication, which results in a
unique replication lesion, with no DSBs, that is separate
from those produced by hydroxyurea. Hydroxyurea
directly inhibits ribonucleotide reductase, depleting all
(dNTP) pools resulting in stalled replication forks and
DSB formation (32). Thymidine eﬃciently induces homol-
ogous recombination at replication forks (32), which
likely involves a template switching mechanism (33).
Here, we tested if also the irs1TofZM14 cells are proﬁcient
in thymidine-induced RAD51 foci as this may explain
the proﬁciency in TAR. We found that the irs1TofZM14
cells were defective in RAD51 foci induced by ionizing
radiation as compared to wild-type cells and proﬁcient in
RAD51 foci formation induced by thymidine (Figure 4B),
which altogether suggests that the irs1TofZM14 cells are
still proﬁcient in a sub-pathway of homologous recombi-
nation repair at replication forks. The deﬁciency in
RAD51 foci formation following ionizing radiation was
reverted by transient transfection with a plasmid contain-
ing wt XRCC2, while not altering the number of RAD51
foci following thymidine treatment, conﬁrming that the
XRCC2 deﬁciency is responsible for the lack of RAD51
foci following ionizing radiation in irs1TofZM14 cells.
DISCUSSION
TAR is a phenomenon present in all investigated cellular
organisms but, in spite of this, the proteins involved in
catalysing TAR are unknown. Here, we show that
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Nucleic AcidsResearch, 2009, Vol.37,No. 2 409BRCA2 is required for TAR, which strongly support that
TAR involves RAD51-mediated strand invasion (34).
This is an expected ﬁnding and therefore, it is more sur-
prising to ﬁnd that the XRCC2 protein is not required for
TAR. The XRCC2 protein was earlier found to be impor-
tant in catalysing DSB-induced homologous recombina-
tion and RAD51 foci formation after ionizing radiation
(18,19,27). Here we report that the irs1 cell line is able
to catalyse TAR and that overexpression of a wild-type
XRCC2 protein does not inﬂuence TAR levels, which
altogether show that XRCC2 is not involved in TAR.
As irs1 cells are functional for TAR, while defective for
DSB-induced homologous recombination, these experi-
ments clearly show that the recombination induced
following transcription is functionally diﬀerent than
homologous recombination induced by an I-SceI-induced
DSB. This ﬁnding is of biological importance as the
two-ended DSB formed by ionizing radiation or an endo-
nuclease likely is a rare event in vivo. However, the
discrepancy of the XRCC2 gene involved in one path-
way, but not another, is anticipated as homologous
recombination is involved in repairing several diﬀerent
types of lesions (33).
Using the irs1TofZM14 and irs1TofZM15 cell lines, we
now have a system to genetically separate TAR from ordi-
nary DSB-induced homologous recombination repair.
Interestingly, it was reported that the irs1 cell line is par-
tially proﬁcient for thymidine-induced homologous
recombination, while defective for DSB or hydroxyurea-
induced homologous recombination (30), which we can
conﬁrm to be the case also in the irs1 cells used here. In
speculation, it is possible that the thymidine-induced and
transcription-induced homologous recombination occur
with similar mechanisms in mammalian cells, a mecha-
nism that appears to be largely distinct from DSB-induced
homologous recombination. We have shown in several
reports that thymidine causes a unique substrate for
homologous recombination, which may involve template
switching to bypass a lesion (33,34,35,36). The DNA poly-
merase is about 20 times faster than RNA polymerase II
and would need to over take the RNA polymerase not to
be slowed down. The model for thymidine-induced recom-
bination may also explain how the RNA polymerase could
be bypassed during replication (Figure 5). There is
already strong support for TAR being connected with rep-
lication in both mammals and yeast (3,9) and it has been
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using homologous recombination, which would account for the transcription-associated recombination reported in this study. This model explains
how the RNA polymerase may be over taken by the DNA polymerase, as well as explaining how the XRCC2 allele in irs1 cells are proﬁcient for
both thymidine and transcription-induced recombination.
410 Nucleic Acids Research, 2009, Vol. 37,No. 2shown in yeast that recombination is induced when a rep-
lication fork hits an elongating RNA polymerase (4).
Also, in mammalian cells TAR is restricted to the
S-phase of the cell cycle and relies on a rapidly moving
replication fork (9).
In conclusion, we show a diﬀerential involvement of the
BRCA2 and XRCC2 proteins in catalysing TAR, demon-
strating that homology directed DSB repair and TAR
employ distinct recombination pathways.
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